• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Biochemical recurrence in prostate cancer: The European Association of Urology prostate cancer guidelines panel recommendations

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Van der Broeck, T
    van den Bergh, R
    Briers, E
    Cornford, P
    Cumberbatch, M
    Tilki, D
    De Santis, M
    Fanti, S
    Fossati, N
    Gillessen, Silke
    Grummet, J
    Henry, A
    Lardas, M
    Liew, M
    Mason, M
    Moris, L
    Schoots, I
    van der Kwast, T
    van der Poel, H
    Wiegel, T
    Willemse, P
    Rouviere, O
    Lam, T
    Mottet, N
    Show allShow less
    Affiliation
    Department of Urology, University Hospitals Leuven, Leuven, Belgium
    Issue Date
    2019
    
    Metadata
    Show full item record
    Abstract
    Biochemical recurrence (BCR) after primary treatment of localized prostate cancer does not necessarily lead to clinically apparent progressive disease. To aid in prognostication, the European Association of urology prostate cancer guidelines panel undertook a systematic review and successfully developed a novel BCR risk stratification system (groups with a low risk or high risk of BCR) based on disease and prostate-specific antigen characteristics. PATIENT SUMMARY: Following treatment to cure prostate cancer, some patients can develop recurrence of disease identified via a prostate-specific antigen blood test (ie, biochemical recurrence, or BCR). However, not every man who experiences BCR develops progressive disease (symptoms or evidence of disease progression on imaging). We conducted a review of the literature and developed a classification system for predicting which patients might progress to optimize treatment decisions.
    Citation
    Van den Broeck T, van den Bergh RCN, Briers E, Cornford P, Cumberbatch M, Tilki D, et al. Biochemical recurrence in prostate cancer: The European Association of Urology prostate cancer guidelines panel recommendations. Eur Urol Focus. 2019.
    Journal
    European Urology Focus
    URI
    http://hdl.handle.net/10541/622048
    DOI
    10.1016/j.euf.2019.06.004
    PubMed ID
    31248850
    Additional Links
    https://dx.doi.org/10.1016/j.euf.2019.06.004
    Type
    Article
    Language
    en
    ae974a485f413a2113503eed53cd6c53
    10.1016/j.euf.2019.06.004
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review.
    • Authors: Van den Broeck T, van den Bergh RCN, Arfi N, Gross T, Moris L, Briers E, Cumberbatch M, De Santis M, Tilki D, Fanti S, Fossati N, Gillessen S, Grummet JP, Henry AM, Lardas M, Liew M, Rouvière O, Pecanka J, Mason MD, Schoots IG, van Der Kwast TH, van Der Poel HG, Wiegel T, Willemse PM, Yuan Y, Lam TB, Cornford P, Mottet N
    • Issue date: 2019 Jun
    • Markers and meaning of primary treatment failure.
    • Authors: Swindle PW, Kattan MW, Scardino PT
    • Issue date: 2003 May
    • Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.
    • Authors: Cookson MS, Aus G, Burnett AL, Canby-Hagino ED, D'Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J, Higano CS, Kraus SR, Moul JW, Tangen C, Thrasher JB, Thompson I
    • Issue date: 2007 Feb
    • [Management of prostate cancer biochemical recurrence in the clinical guidelines].
    • Authors: Fernández CH, Patiño GE, Merino RD, Chomón GB, Rios DS, Gárate MM, Gil MJ
    • Issue date: 2012 Jan-Feb
    • Preoperative predictive factors and further risk stratification of biochemical recurrence in clinically localized high-risk prostate cancer.
    • Authors: Hamada R, Nakashima J, Ohori M, Ohno Y, Komori O, Yoshioka K, Tachibana M
    • Issue date: 2016 Jun
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.